[1]
Alfatli, L.A.R. and Tweij, T.-A.R. 2025. Aprocitentan mitigates ischemia reperfusion induced kidney injury in rats by attenuating inflammation and pyroptosis through suppressing NF-κB/NLRP3/caspase-1 signaling pathway. European Journal of Clinical and Experimental Medicine. 23, 4 (Dec. 2025), 936–946. DOI:https://doi.org/10.15584/ejcem.2025.4.13.